Device Settlements Contribute To DoJ's $2.5Bn Health-Care FCA Haul
Executive Summary
The US Department of Justice collected $2.8bn in settlements and judgments involving violations of the False Claims Act in 2018, including $2.5bn in health-care cases. Key device industry recoveries included $33.2m from Alere, $12.5m from Angiodynamics, and $30m in two separate settlements from Covidien and its subsidiary ev3.
You may also be interested in...
New AG William Barr May Bring A Lighter Touch On FCA Enforcement
During his January confirmation hearing, new Attorney General William Barr promised to uphold the False Claims Act. But his past statements condemning the law have some wondering how vigorous that enforcement will be.
Medtronic Biz Pleads Guilty In Off-Label Marketing Case
A Medtronic subsidiary has agreed to plead guilty for off-label marketing activities that occurred prior to Medtronic's acquisition. Overall, the firm says it has settled three investigations with a total pay-out of $50.9m. US FDA is underscoring the case as an example of the agency pursuing companies that "put profit over safety."
AngioDynamics To Resolve US Federal Claims With $12.5M Payout
Device-maker AngioDynamics has agreed to pay $12.5m to resolve allegations the company encouraged health-care providers to submit false claims for two of the company’s products.